Healthcare Sales & Marketing Network News: Shire

Searching News Database: Shire

HSMN NewsFeed - 17 Apr 2024
Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 7 Feb 2023
CraniUS Appoints Industry-Leading Executive in MedTech Space to Serve as Vice-Chair on Board of Directors
Devices Drug Delivery Personnel

HSMN NewsFeed - 18 Jan 2023
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2022
INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Dec 2021
Nordic Nanovector appoints Experienced International Life Sciences Executive Sandra Jonsson as Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 14 Dec 2021
MindMed Appoints Robert Barrow as Chief Executive Officer and Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2021
Mirati Therapeutics Appoints David Meek as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Jul 2021
Corium Launches Innovative ADHD Treatment AZSTARYS(TM) (serdexmethylphenidate and dexmethylphenidate) in the U.S. for Patients Age 6 Years and Older
Biopharmaceutical Neurology Product Launch

HSMN NewsFeed - 15 Jun 2021
Senda Biosciences Strengthens Leadership Team with Key Management Hires
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2021
Modeling Data Showed Cologuard(R) Was Superior to Fecal Immunochemical Test (FIT) on Cost Effectiveness and Colorectal Cancer Incidence and Mortality
Diagnostics Oncology

HSMN NewsFeed - 30 Dec 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 13 Aug 2020
Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay's MRIdian Linac
Devices Radiology Oncology

HSMN NewsFeed - 15 Jun 2020
Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat(R) Research
Diagnostics Oncology Distribution

HSMN NewsFeed - 9 Jun 2020
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2020
Protalix BioTherapeutics Announces Positive Topline Results from the BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 4 May 2020
Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 17 Apr 2020
PTC Therapeutics Announces New Leadership Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Mar 2020
Pristine Surgical completes $18 million capital raise
Devices Surgery Venture Capital

HSMN NewsFeed - 19 Dec 2019
Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2019
Lannett To Commence Marketing Generic Adderall(R) XR
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 18 Jul 2019
Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 17 May 2019
Exact Sciences Presents New Data Reinforcing Performance of Cologuard(R)
Diagnostics Gastroenterology Oncology

HSMN NewsFeed - 10 May 2019
Rani Therapeutics Hires First CFO
Devices Drug Delivery Personnel

HSMN NewsFeed - 21 Feb 2019
Enzyvant Appoints Industry Veteran Rachelle Jacques as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Feb 2019
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2018
EUSA Pharma Appoints Jeffrey S. Hackman as President US Operations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Nov 2018
FDA Approves AEMCOLO(TM) (rifamycin), the First Antibiotic Approved for the Treatment of Travelers' Diarrhea in Over a Decade
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 10 Oct 2018
Tris Pharma Announces Hiring of Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Aug 2018
BD Elects Jeffrey Henderson to Board of Directors
Devices Personnel

HSMN NewsFeed - 17 Jul 2018
Spruce Biosciences Appoints David Moriarty, Ph.D., as Vice President of Development Operations
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 10 May 2018
Aldeyra Therapeutics Appoints David McMullin as Senior Vice President, Corporate Development and Strategy
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 30 Apr 2018
Forty Seven Inc. Appoints Ian T. Clark to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 10 Apr 2018
Former CoLucid CEO Thomas P. Mathers joins Pappas Capital as Partner
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 4 Apr 2018
Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Apr 2018
Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Mar 2018
Tyber Medical Announces the Limited Release of the Sterile Comprehensive Forefoot Procedure Kit
Devices Orthopaedic Product Launch

HSMN NewsFeed - 5 Mar 2018
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 22 Feb 2018
Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 26 Jan 2018
Vascular Insights(R) Announces New Chief Executive Officer
Devices Interventional Personnel

HSMN NewsFeed - 22 Jan 2018
Elanco Animal Health Announces U.S. Food and Drug Administration (FDA) Approval of Credelio(R) (lotilaner) to Treat and Protect Against Ticks and Fleas
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Jan 2018
Enterome Raises €32 Million ($38.5 Million) in a Series D Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 13 Nov 2017
Spruce Biosciences Appoints Camilla V. Simpson to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Oct 2017
SutroVax Appoints Veteran Vaccine Experts to Executive Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2017
BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Aug 2017
Milestone Pharmaceuticals Closes $55 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 11 Jul 2017
Enterome and Nestlé Health Science Launch New Diagnostics Company
Diagnostics

HSMN NewsFeed - 11 Jul 2017
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 6 Jul 2017
Viking Therapeutics Appoints Charles A. Rowland Jr. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2017
Arbor Pharmaceuticals, LLC and Debiopharm International SA Announce U.S. FDA Approval for Triptodur(TM), Triptorelin 6-month Formulation, in the Treatment of Central Precocious Puberty (CPP)
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Jun 2017
Merrimack Announces Expansion of Senior Management Team with Appointment of Sergio Santillana as Chief Medical Officer and Ellen Forest as Head of Human Resources
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Jun 2017
Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Jun 2017
PTC Therapeutics Announces Executive Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 May 2017
Homology Medicines Strengthens Manufacturing and Product Development Expertise with Appointment of Tim Kelly as Senior Vice President, Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2017
Alcobra Announces Leadership Update
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2017
Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 26 Apr 2017
John Tucker appointed as Chief Executive Officer of scPharmaceuticals
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 16 Mar 2017
Shire Receives European Approval for Label Extension of CINRYZE(R) (C1 inhibitor ) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Mar 2017
Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-913 Genome Editing Treatment for MPS II
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Feb 2017
Sangamo Therapeutics Announces Chief Financial Officer Succession
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 21 Feb 2017
Bristol-Myers Squibb Appoints Three New Independent Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2017
Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jan 2017
Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2017
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 27 Dec 2016
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Nov 2016
Bristol-Myers Squibb and Enterome SA Announce Immuno-Oncology Collaboration Focused on Microbiome-derived Biomarkers, Drug Targets and Bioactive Molecules
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 3 Nov 2016
Enterome Appoints Christophe Bonny as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Oct 2016
Shire Granted EU Marketing Authorization of Onivyde(R), in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV),for the Treatment of Metastatic Adenocarcinoma of the Pancreas in Adult Patients Who Have Progressed Following Gemcitabine-Based Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 6 Oct 2016
Kamada Announces Extension of GLASSIA(R) Supply and Distribution Agreement with Shire with Minimum $237 Million of Revenue for the Years 2017 to 2020
Biopharmaceuticals Distribution Licensing

HSMN NewsFeed - 27 Sep 2016
Insmed Appoints Roger Adsett as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Sep 2016
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Aug 2016
Shire Announces FDA Approval of adynovate with BAXJECT III Reconstitution System
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jul 2016
ONIVYDE(R) Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Following Gemcitabine Based Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 19 Jul 2016
Preceptis Medical Launches the Hummingbird(TM) TTS Ear Tube Delivery System
Devices Product Launch

HSMN NewsFeed - 12 Jul 2016
FDA Approves Shire’s Xiidra(TM) (lifitegrast ophthalmic solution) 5% – The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 7 Jul 2016
Shire Receives Extension of Market Authorization in Europe for Revestive(R) (Teduglutide) for the Treatment of Paediatric Patients with Short Bowel Syndrome (SBS)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Jun 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II
Biopharmaceuticals FDA

HSMN NewsFeed - 16 May 2016
Neos Therapeutics Announces U.S. Launch of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients Six Years and Older
Biopharmaceuticals Product Launch

HSMN NewsFeed - 20 Apr 2016
Enterome Raises EUR14.5 Million in Series C Financing Round
Biopharmaceuticals Gastroenterology Venture Capital

HSMN NewsFeed - 18 Apr 2016
Joseph Horrigan Joins AMO Pharma as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2016
Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Mar 2016
Shire Wins Patent Trial Against Watson Concerning LIALDA(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 24 Mar 2016
Juniper Pharmaceuticals Appoints Mary Ann Gray, Ph.D., to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Mar 2016
Medgenics Hires Rick Couch, Ph.D. to Vice President of Chemistry, Manufacturing and Controls
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 8 Feb 2016
Global Blood Therapeutics Announces Changes to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2016
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 26 Jan 2016
Inivata Completes £31.5 Million ($45M) Series A Fundraising Round
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 15 Dec 2015
eFFECTOR Therapeutics Appoints Alana McNulty Chief Financial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Dec 2015
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Nov 2015
Amplyx Pharmaceuticals Secures $40.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 2 Nov 2015
Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 10 Sep 2015
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 8 Sep 2015
Vanda Pharmaceuticals Announces the Appointment of European General Manager
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Sep 2015
Summit Therapeutics Appoints Ralf Rosskamp, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jul 2015
Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jul 2015
Strensiq(R) (asfotase alfa) Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia (HPP)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Jun 2015
Amicus Therapeutics Strengthens Executive Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2015
PTC Therapeutics Names Eric Pauwels SVP & General Manager Commercial Operations, Americas
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2015
ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Feb 2015
Shire Acquires Meritage Pharma
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 Feb 2015
PerkinElmer Elects Sylvie Grégoire to its Board of Directors
Devices Personnel

HSMN NewsFeed - 29 Dec 2014
BioTime Appoints Adi Mohanty Chief Operating Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 24 Nov 2014
Agilis Biotherapeutics Names Former Shire Executive Dr. Gregory Robinson as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Oct 2014
Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 20 Oct 2014
Interim Chief Financial Officer James Bowling to Step Down
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Oct 2014
Cortendo Appoints Robert Lutz as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2014
Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Aug 2014
Health Canada Approves Eloctate(TM), the First Therapy to Extend the Interval Between Prophylactic Infusions in Hemophilia A
Biopharmaceuticals Regulatory

HSMN NewsFeed - 13 Aug 2014
Tarsa Therapeutics Secures $10 Million And Adds Industry Veteran Daniel Soland As A Director
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 7 Aug 2014
Cortendo Appoints Matthew Pauls as Chief Executive Officer
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 23 Jul 2014
Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 19 May 2014
Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in Adults
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 5 May 2014
SAGE Therapeutics Appoints Thomas D. Anderson as Chief Commercial Strategy Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2014
Dr. Edward Rudnic Appointed CEO of QRxPharma
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2014
BOTOX(R) (Botulinum Toxin Type A) Receives a Positive Opinion in Fourteen European Countries for the Treatment of Focal Spasticity of the Ankle in Adult Post Stroke Patients
Biopharmaceuticals Regulatory

HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
Diagnostics Cardiology Distribution

HSMN NewsFeed - 7 Apr 2014
EndoBarrier(R) Therapy Receives Reimbursement Coverage in Israel
Devices Reimbursement

HSMN NewsFeed - 2 Apr 2014
ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Apr 2014
Trevena Appoints Robert Prachar as Senior Vice President, Commercial and Corporate Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Mar 2014
Osiris Therapeutics Announces Therésa K. Dixon as General Manager of Market Access and Reimbursement
Regenerative Medicine Personnel

HSMN NewsFeed - 24 Mar 2014
Health Canada Approves Biogen Idec's Long-Acting ALPROLIX(TM) Therapy for Hemophilia B
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Mar 2014
Revance to Add Angus C. Russell as Chairman to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Feb 2014
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Feb 2014
BOTOX(R) (Botulinum toxin type A) Receives Approval in the UK for the Treatment of Ankle Disability due to Lower Limb Spasticity Associated with Stroke in Adults
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 23 Jan 2014
Susan Kilsby to Succeed Matthew Emmens as Chairman of Shire
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jan 2014
Organogenesis Inc. Announces Acquisition of Dermagraft(R) from Shire
Devices Wound Care Acquisitions

HSMN NewsFeed - 17 Jan 2014
Shire Executes Agreement to Divest DERMAGRAFT(R)
Devices Wound Care Acquisitions

HSMN NewsFeed - 13 Jan 2014
Galena Biopharma Acquires Mills Pharmaceuticals, LLC
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 Jan 2014
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Biopharmaceuticals

HSMN NewsFeed - 7 Jan 2014
KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Dec 2013
Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Nov 2013
Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio; Will Augment Already Strong Growth Prospects
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Oct 2013
Mallinckrodt Pharmaceuticals Announces Executive Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Oct 2013
Moximed Initiates Study in UK of KineSpring(R) System in Patients with Knee Osteoarthritis
Devices Orthopaedic

HSMN NewsFeed - 17 Sep 2013
InVivo Therapeutics Appoints Gregory D. Perry as Interim CFO
Devices Neurosurgery Personnel

HSMN NewsFeed - 9 Sep 2013
ImmusanT Names Ferdinand E. Massari as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Sep 2013
Vital Therapies, Inc. Expands Executive Team
Devices Regenerative Medicine Personnel

HSMN NewsFeed - 26 Aug 2013
Sangamo BioSciences to Acquire Ceregene
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 21 Aug 2013
Ironwood Pharmaceuticals Appoints Dr. Michael Hall as Senior Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Aug 2013
SAGE Therapeutics Appoints Biotech Industry Veteran Dr. Jeffrey Jonas to Chief Executive Officer; Expands Leadership Team with Two Key Appointments
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 30 Jul 2013
Alcobra Ltd. Appoints Dr. Jonathan Rubin as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2013
Third Rock Ventures Expands and Strengthens Team
Biopharmaceuticals Devices Venture Capital Personnel

HSMN NewsFeed - 6 May 2013
NeuroPhage, Inc. Raises $6.4 Million In Additional Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 12 Mar 2013
Shire Acquires Premacure AB
Biopharmaceuticals Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 8 Feb 2013
Impax and Shire Settle Litigation Concerning Supply of Authorized Generic Adderall XR(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 7 Jan 2013
Ambrx Appoints Lawson Macartney, Ph.D., DVM, Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Dec 2012
Naurex Completes $38 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital Personnel

HSMN NewsFeed - 10 Dec 2012
TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Nov 2012
Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 12 Nov 2012
Trinity Medical Center Adds Masimo Patient SafetyNet(TM) as a High Vigilance Safeguard for Post-Surgical Patients
Devices Monitoring

HSMN NewsFeed - 28 Oct 2012
Accuray Launches New TomoTherapy(R) H(TM) Series Featuring TomoEDGE(TM)
Devices Oncology

HSMN NewsFeed - 15 Oct 2012
Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 9 Oct 2012
Moximed's Implantable Knee Spring Successfully Reduces Pain and Quickly Returns Normal Function to Osteoarthritis Patients
Devices Orthopaedic

HSMN NewsFeed - 5 Sep 2012
DERMAGRAFT(R) Approved in Canada for Treatment of Diabetic Foot Ulcers
Devices Wound Care Regulatory

HSMN NewsFeed - 2 Aug 2012
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2012
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 May 2012
Internal Fixation Systems Enters Into a Distribution Agreement With Intelligent Orthopaedics
Devices Orthopaedic Distribution

HSMN NewsFeed - 10 May 2012
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Apr 2012
Heart Failure Patients Demonstrate Impressive Improvement With Novel, Less Invasive Technique Using BioVentrix Therapy
Devices Cardiology

HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Mar 2012
Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 10 Jan 2012
Shire Acquires US Rights to Resolor(R) (prucalopride)
Biopharmaceuticals Licensing

HSMN NewsFeed - 18 Nov 2011
Shire Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd.
Biopharmaceuticals

HSMN NewsFeed - 26 Sep 2011
NPS Pharmaceuticals Appoints Eric Pauwels as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jul 2011
Celldex Expands Senior Management Team with Appointment of Dr. Ronald A. Pepin, Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Apr 2011
NeurogesX CEO Anthony DiTonno to Retire by Year End
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Apr 2011
Shire Files Lawsuit Against Watson Pharmaceuticals, Inc. for Infringement of ADDERALL XR(R) Patents and for Breach of Contract
Biopharmaceuticals Litigation

HSMN NewsFeed - 22 Mar 2011
Data Presented at AAAAI Annual Meeting Further Support the Safety and Efficacy of FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 17 Mar 2011
KaloBios Announces Two Significant Additions to Its Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Mar 2011
NeuroPhage Pharmaceuticals Closes $12.4M Series B Round
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 28 Feb 2011
FDA Approves INTUNIV(R) (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Feb 2011
Shire Files Complete Response to FDA's Not Approvable Letter for FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Dec 2010
Shire Files Suit Against Impax and Watson
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 6 Oct 2010
DiFUSION Technologies Adds Accomplished Senior Management Team
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Jul 2010
Lialda(R) - Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 30 Jun 2010
Celgene to Acquire Abraxis BioScience Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 Jun 2010
Breast Cancer Reconstruction Using Cell-Enriched Fat Grafts Shows Continued High Rates of Physician and Patient Satisfaction at 12 Months
Regenerative Medicine Oncology

HSMN NewsFeed - 23 Apr 2010
INTUNIV(TM) - Shire Files Suit Against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd.
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 13 Apr 2010
K-V Pharmaceutical Appoints New Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Mar 2010
Vidacare's OnControlTM Bone Marrow System Is Quantum Leap Forward for Bone Marrow Procedures
Devices Oncology

HSMN NewsFeed - 24 Feb 2010
Shire Provides Update on Biologics License Application (BLA) Filing for REPLAGAL(R) (agalsidase alfa) With the U.S. Food and Drug Administration (FDA)
Biopharmaceuticals

HSMN NewsFeed - 20 Jan 2010
Antares Pharma Expands Executive Team and Appoints Pavan Handa as Senior Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Dec 2009
Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)
Biopharmaceuticals

HSMN NewsFeed - 28 Oct 2009
Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 Oct 2009
FDA Determines VYVANSE(R) was Properly Granted Five-Year Market Exclusivity
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Oct 2009
Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
Biopharmaceuticals

HSMN NewsFeed - 23 Sep 2009
U.K. NICE Updates Clinical Guidelines to Support Use of Essure(R)
Devices

HSMN NewsFeed - 3 Sep 2009
Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Sep 2009
Leading UK Hospital First to Install FORE-SIGHT Absolute Cerebral Oximetry
Devices Monitoring

HSMN NewsFeed - 1 Sep 2009
Multiple Presentations at the European Society of Cardiology Congress Document EECP Promotes Coronary Collateral Flow Leading to Sustained Clinical Improvement
Devices Cardiology

HSMN NewsFeed - 3 Aug 2009
Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jul 2009
Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Jul 2009
Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jul 2009
Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
Biopharmaceuticals

HSMN NewsFeed - 9 Jun 2009
William Aliski Named FoldRx Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Apr 2009
ARIAD Appoints Former Bristol-Myers Squibb Senior Executive as New Independent Member of Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Apr 2009
Teva Introduces First Generic Adderall XR Capsules in the United States
Biopharmaceuticals Generics

HSMN NewsFeed - 2 Apr 2009
Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 31 Mar 2009
Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
Biopharmaceuticals

HSMN NewsFeed - 20 Mar 2009
Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 20 Mar 2009
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
Biopharmaceuticals Product Recall

HSMN NewsFeed - 18 Mar 2009
FIRMAGON(R) (Degarelix) is Launched in Europe for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Mar 2009
Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 16 Mar 2009
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Mar 2009
Shire Announces Launch of FOSRENOL(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Feb 2009
UCB to divest Equasym(R)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 20 Feb 2009
Shire Announces Opening of Office in Japan
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Feb 2009
Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 9 Feb 2009
Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
Biopharmaceuticals Generics

HSMN NewsFeed - 6 Jan 2009
ARIAD Expands Management Team with Executive Appointments in Regulatory Affairs, Manufacturing and Information Technology
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Dec 2008
Salient Surgical Technologies, Inc. Completes Move to New Corporate Headquarters
Devices

HSMN NewsFeed - 15 Dec 2008
COSMO ANNOUNCES STRATEGIC COLLABORATION WITH SANTARUS FOR U.S. RIGHTS TO BUDESONIDE MMX® AND RIFAMYCIN SV MMX®
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 11 Dec 2008
Algeta Appoints Andrew Kay as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Dec 2008
Prostate Cancer Patient from Warrington Becomes First in UK to Be Treated Using RapidArc(TM) Radiotherapy from Varian Medical Systems
Devices Oncology

HSMN NewsFeed - 7 Oct 2008
Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
Biopharmaceuticals

HSMN NewsFeed - 3 Sep 2008
Rib-X Pharmaceuticals, Inc. Appoints Dr. Joseph Amprey of MedImmune Ventures to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2008
Hansen Medical Announces World's First Robotic Transvascular Aneurysm Repair
Devices Interventional

HSMN NewsFeed - 25 Aug 2008
Noven Provides Update on Daytrana(R) Methylphenidate Transdermal System
Biopharmaceuticals Product Recall

HSMN NewsFeed - 25 Aug 2008
Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 31 Jul 2008
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Jul 2008
Vaccine Executive Staph Bakali Joins Genocea Biosciences' Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jul 2008
Jerini Receives European Commission Approval for FIRAZYR(R) (Icatibant) in the Treatment of HAE
Biopharmaceuticals Regulatory

HSMN NewsFeed - 3 Jul 2008
Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 Jun 2008
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals Product Recall

HSMN NewsFeed - 27 May 2008
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Apr 2008
Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Apr 2008
FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Apr 2008
CoNCERT Pharmaceuticals Announces Appointment of Justine Koenigsberg as Senior Director, Corporate Communications and Investor Relations
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Apr 2008
Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Apr 2008
Portrait(R) Plasma Receives Clearance from the FDA to Treat Acne Scars
Devices Dermatology FDA

HSMN NewsFeed - 27 Mar 2008
Positive Phase III Data Unveiled for New GnRH Blocker Degarelix
Biopharmaceuticals Urology

HSMN NewsFeed - 26 Mar 2008
Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 20 Mar 2008
Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan

HSMN NewsFeed - 25 Feb 2008
Mylan Announces Appointment of Eric M. Leeds as Senior Vice President and Head of Global Investor Relations
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Feb 2008
Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Feb 2008
Altus Pharmaceuticals Announces Executive Management Changes; Altus Announces Resignation of Sheldon Berkle as President and CEO; Board Names Chairman of the Board, David D. Pendergast, Ph.D., as Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jan 2008
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
Biopharmaceuticals

HSMN NewsFeed - 15 Jan 2008
Shire Announces Further Expansion Into Latin America
Biopharmaceuticals

HSMN NewsFeed - 3 Jan 2008
FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Jan 2008
Noven Announces Changes to Board of Directors and Senior Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Dec 2007
Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
Biopharmaceuticals Licensing Gastroenterology

HSMN NewsFeed - 14 Dec 2007
Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
Biopharmaceuticals Licensing Gastroenterology

HSMN NewsFeed - 11 Dec 2007
PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
Biopharmaceuticals

HSMN NewsFeed - 10 Dec 2007
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2007
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
Biopharmaceuticals

HSMN NewsFeed - 8 Nov 2007
Amicus Therapeutics and Shire plc Enter Into $440 Million ex-US Licensing Agreement to Develop and Commercialize Amigal(TM), Plicera(TM) and At2220
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Nov 2007
Shire Expands its Human Genetic Therapies Pipeline Through In-Licensing Agreement With Amicus Therapeutics
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Nov 2007
Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients
Biopharmaceuticals

HSMN NewsFeed - 31 Oct 2007
David Mott Appointed Non Executive Director at Shire
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Oct 2007
Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting
Biopharmaceuticals

HSMN NewsFeed - 25 Oct 2007
Elixir Pharmaceuticals Names Paul M. Martha, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Oct 2007
FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia
Biopharmaceuticals

HSMN NewsFeed - 9 Oct 2007
Robert E. Kirby Appointed President & Chief Executive Officer of Accellent Inc.
Devices Personnel

HSMN NewsFeed - 8 Oct 2007
Shire Divests Non-Core Product Portfolio to Almirall
Biopharmaceuticals Dermatology

HSMN NewsFeed - 4 Oct 2007
Genzyme Receives Approval to Market Elaprase(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Oct 2007
Shire's ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Oct 2007
Pro-Pharmaceuticals Names Anthony Squeglia Chief Financial Officer; Steven Schubert Vice President Finance
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Sep 2007
Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Sep 2007
Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 6 Sep 2007
Shire Appoints Anita Graham to the Newly Created Position of Chief Administrative Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Sep 2007
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 4 Sep 2007
Shire Voluntarily Withdraws a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 23 Aug 2007
Cytochroma announces appointment of Gordon Ngan, CFA, MBA as Executive Director, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Aug 2007
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Biopharmaceuticals

HSMN NewsFeed - 15 Aug 2007
Noven Completes Acquisition of JDS Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Aug 2007
Paladin Expands Distribution Agreement with Shire HGT to Include ELAPRASE(TM) (Idursulfase)
Biopharmaceuticals Distribution

HSMN NewsFeed - 27 Jul 2007
Shire's New ADHD Medication, VYVANSE(TM) (lisdexamfetamine dimesylate) Now Available in U.S. Pharmacies Nationwide
Biopharmaceuticals

HSMN NewsFeed - 10 Jul 2007
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Jun 2007
Shire Announces Filing of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults
Biopharmaceuticals

HSMN NewsFeed - 22 Jun 2007
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Jun 2007
Shire Receives Approvable Letter From FDA for INTUNIV(TM) (guanfacine) Extended Release, a Nonstimulant for the Treatment of ADHD
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Jun 2007
Noven & Shire to Develop New Transdermal Patch For ADHD
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 20 Jun 2007
Shire In-Licenses JUVISTA(R) (Human TGFbeta3) From Renovo
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Jun 2007
Shire's ELAPRASE(TM) (idursulfase) Approved by Health Canada for Treatment of Hunter Syndrome
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Jun 2007
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients
Biopharmaceuticals

HSMN NewsFeed - 4 Jun 2007
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 May 2007
Perceptronix Brings Early Lung Cancer Detection to UK By Signing Service Agreement With University Hospital of Coventry and Warwickshire NHS Trust
Diagnostics Oncology

HSMN NewsFeed - 24 May 2007
Exactech, Inc. Names James G. Binch to Board of Directors
Devices Orthopaedic Personnel

HSMN NewsFeed - 22 May 2007
Shire Human Genetic Therapies AB Signs Exclusive Marketing and Distribution Deal With Samaritan to Launch REPLAGAL for Fabry Disease in Greece and Cyprus
Biopharmaceuticals Distribution

HSMN NewsFeed - 22 May 2007
Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of LIALDA(TM) (mesalamine) Presented at DDW
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 19 May 2007
FDA Issues Approvable Letter for SPD465 (Triple-Bead Mixed Amphetamine Salts) for the Treatment of ADHD in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 17 May 2007
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 16 May 2007
Halozyme Therapeutics Names Randal J. Kirk and Kathryn E. Falberg to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 May 2007
VYVANSE(TM) (lisdexamfetamine dimesylate) Receives Final DEA Schedule Classification, Clearing Way for Launch of First Prodrug Stimulant for Treatment of ADHD
Biopharmaceuticals

HSMN NewsFeed - 2 May 2007
Paladin Acquires Products from Shire
Biopharmaceuticals Dermatology Acquisitions

HSMN NewsFeed - 1 May 2007
New Hampshire Law Banning Commercial Use of Prescription Information Declared Unconstitutional
Biopharmaceuticals Litigation

HSMN NewsFeed - 30 Apr 2007
Greatbatch and Enpath Sign Definitive Merger Agreement
Devices Mergers & Acquisitions

HSMN NewsFeed - 20 Apr 2007
Shire Completes Acquisition of New River
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Apr 2007
Shire Successfully Completes Tender Offer for New River Shares
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Mar 2007
ADDERALL XR(R) - Shire Files Suit Against Colony Pharmaceuticals, Inc., Actavis, Inc. and Actavis Group hf
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 20 Mar 2007
Shire Begins External Search for President of Successful Human Genetic Therapies Business, on Retirement of David Pendergast at the End of 2007
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2007
LIALDA(TM) (mesalamine) With MMX(TM) Technology - the First Oral Once-Daily Mesalamine for Active, Mild to Moderate Ulcerative Colitis - Now Available
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 5 Mar 2007
UK Launch Expands Global Reach of FOSRENOL(R)
Biopharmaceuticals

HSMN NewsFeed - 27 Feb 2007
Exeter Hospital First Hospital in New Hampshire to Deploy Zoll AutoPulse
Devices Cardiology

HSMN NewsFeed - 20 Feb 2007
Shire Agrees to Acquire New River to Gain Full Control of VYVANSE(TM), its Future Flagship Product for ADHD
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Jan 2007
Synta Pharmaceuticals Corp. Announces Additions to Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jan 2007
FDA Approves LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 11 Jan 2007
ELAPRASE(R) for the Treatment of Hunter Syndrome Approved by the European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Jan 2007
The European Commission Approves First and Only Enzyme Replacement Therapy for Hunter Syndrome
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Dec 2006
New River Pharmaceuticals and Shire Receive Approvable Letter for VYVANSE(TM) (lisdexamfetamine dimesylate) for the Treatment of ADHD
Biopharmaceuticals

HSMN NewsFeed - 12 Dec 2006
Dr. Jeffrey Leiden Appointed Non Executive Director at Shire
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Nov 2006
Altus Pharmaceuticals Appoints Shire Executive David Pendergast to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Nov 2006
New Analyses Demonstrate Positive Effect on Bone With Fosrenol(R) Treatment Compared With Standard Therapy
Biopharmaceuticals

HSMN NewsFeed - 17 Nov 2006
FOSRENOL(R) Data Show Evidence of Trends Towards Improved Bone Formation in CKD Stage 5 Patients, New Data Presented at ASN Meeting
Biopharmaceuticals

HSMN NewsFeed - 16 Nov 2006
Shire Announces Study Results With Once-Daily Guanfacine Extended Release (GXR) in ADHD Patients Aged 6-17
Biopharmaceuticals

HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
Biopharmaceuticals

HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of a Meta-Analysis Comparing Stimulant Medications to Non-Stimulant Medications in Treating ADHD in Patients Aged 8 to 15
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
Biopharmaceuticals Regulatory Generics

HSMN NewsFeed - 10 Nov 2006
Shire Sues Andrx Pharmaceuticals, L.L.C.
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 6 Nov 2006
Atrium's Chest Drain CE Program Now Exclusively Online
Devices

HSMN NewsFeed - 26 Oct 2006
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
Biopharmaceuticals

HSMN NewsFeed - 19 Oct 2006
ELAPRASE(TM) (idursulfase) Receives Positive Opinion in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 13 Oct 2006
Pfizer Names Senior Executive to Head Expanded Worldwide Licensing and Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Oct 2006
New River Pharmaceuticals Inc. Receives Approvable Letter for NRP104
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Sep 2006
Barr Cleared to Launch ADDERALL(R) IR
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 25 Sep 2006
Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Sep 2006
Genmab Initiates HuMax-EGFr Pivotal Study In Refractory Head and Neck Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Sep 2006
iCAD Announces the Appointment of Darlene Deptula-Hicks as Chief Financial Officer
Devices Oncology Radiology Personnel

HSMN NewsFeed - 8 Sep 2006
Shire Provides Update on U.S. Marketing Application of MESAVANCE(TM) (mesalamine) With MMX Technology
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 21 Jul 2006
CardiacAssist Places TandemHeart(R) PTVA(R) System at Three New Medical Centers
Devices Cardiology

HSMN NewsFeed - 11 Jul 2006
IMPAX Announces the Launch of IMPAX Pharmaceuticals
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2006
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2006
Shire's DAYTRANA(TM), First Transdermal Medication for Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children, Now Available in Pharmacies
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 25 May 2006
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
Biopharmaceuticals

HSMN NewsFeed - 24 May 2006
Positive Study Results for DAYTRANA(TM) (methylphenidate transdermal system) Presented at a Major Medical Meeting
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 17 May 2006
Carrington Appoints New Vice President, Corporate Sales & Marketing
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 214

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 214 additional stories matching:
Shire
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.